16 July 2024
NZX/ASX Code: EBO
EBOS and Prime100 Media Speculation
EBOS Group Limited (“EBOS”) notes media commentary (Financial Review – Street Talk, 15 July 2024) speculating on EBOS’ interest in the potential sale of pet food business Prime100.
EBOS advises it will not be participating in any potential forthcoming sale of Prime100.
Authorised for lodgement with NZX and ASX by:
Janelle Cain
General Counsel
EBOS Group Limited
+61 3 9918 5555
About EBOS Group
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.
The company faced the greatest challenges in the sector.
Investors may not be showing NZ firms love, but private equity will.
Bid from Australian private equity firm values shares at between $1.50 and $1.70.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details